BIOMAT Database Logo BIOMAT Database Logo

Does treatment of predialysis patients with recombinant human erythropoietin compromise renal function? 1990

R A Koene, and L A Frenken
Department of Medicine, University Hospital, Nijmegen, The Netherlands.

UI MeSH Term Description Entries
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D004921 Erythropoietin Glycoprotein hormone, secreted chiefly by the KIDNEY in the adult and the LIVER in the FETUS, that acts on erythroid stem cells of the BONE MARROW to stimulate proliferation and differentiation.
D005260 Female Females
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

R A Koene, and L A Frenken
[Effect of recombinant human erythropoietin on renal function in predialysis patients].
June 1991, Nihon Jinzo Gakkai shi,
R A Koene, and L A Frenken
Effects of recombinant human erythropoietin on renal function in chronic renal failure predialysis patients.
November 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation,
R A Koene, and L A Frenken
Recombinant human erythropoietin in predialysis patients.
October 1991, American journal of kidney diseases : the official journal of the National Kidney Foundation,
R A Koene, and L A Frenken
[Anaemia treatment with recombinant human erythropoietin in predialysis patients with chronic renal failure--own experience].
October 2003, Polskie Archiwum Medycyny Wewnetrznej,
R A Koene, and L A Frenken
Cost of treating predialysis patients with recombinant human erythropoietin.
January 1993, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
R A Koene, and L A Frenken
Effects of human recombinant erythropoietin on anaemia, systemic haemodynamics and renal function in predialysis renal failure patients.
January 1989, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
R A Koene, and L A Frenken
Recombinant human erythropoietin for anaemia associated with chronic renal failure in predialysis patients.
January 1992, Przeglad lekarski,
R A Koene, and L A Frenken
Erythropoietin treatment does not compromise cardiovascular function in chronic renal failure.
March 1994, Angiology,
R A Koene, and L A Frenken
[Study of recombinant human erythropoietin treatment on the anemia of predialysis patients].
June 1992, Nihon Jinzo Gakkai shi,
R A Koene, and L A Frenken
The use of recombinant human erythropoietin in predialysis patients.
March 1995, Current opinion in nephrology and hypertension,
Copied contents to your clipboard!